Research Article
A Pilot Study of the Combination of Entinostat with Capecitabine in Advanced Breast Cancer
Table 4
Summary dose-limiting toxicity table.
| | Arm | Arm description | # pts w/ DLT | # pts total | % | CI lower | CI upper |
| | C1 | Entinostat 3 mg, capecitabine 800 mg | 0 | 3 | 0 | 0 | 63.2 | | C2 | Entinostat 5 mg, capecitabine 800 mg | 1 | 4 | 25 | 1.3 | 75.1 | | C3 | Entinostat 3 mg, capecitabine 1000 mg | 0 | 4 | 0 | 0 | 52.7 | | C4 | Entinostat 5 mg, capecitabine 1000 mg | 0 | 2 | 0 | 0 | 77.6 |
|
|
